Endometriosis is a disease characterized by endometrial tissue (the tissue that lines the uterus) growing outside the uterus, forming lesions. Endometrial lesions may occur on the abdominal wall, the ovaries, the bowel, or the bladder. They swell and shed with the menstrual cycle just like the normal endometrium, but as they are located outside the uterus, cannot exit the body. This causes inflammation leading to pain and infertility.

While there is no cure for endometriosis, there are treatments that can help, including hormonal treatments. Aromatase inhibitors are a class of hormonal treatment used in combination with others to treat pain in endometriosis.

What are aromatase inhibitors?

Aromatase inhibitors are molecules that inhibit an enzyme called aromatase. Aromatase is present in the ovaries, and to a lesser extent in the skin and fat tissue. Its function is to produce estrogen. In endometriosis, estrogen regulates the hormone cycle that controls the swelling and shedding of endometrial lesions. In addition, endometrial lesions have a large amount of aromatase. This is thought to exacerbate the symptoms of endometriosis because aromatase provides additional estrogen to the endometrial lesions.

By blocking aromatase, aromatase inhibitors reduce the amount of estrogen being produced by the body and the endometrial lesions. With less estrogen present, the lesions do not grow or shed.

Aromatase inhibitors must be used with either a hormonal birth control or a gonadotropin-releasing hormone (GnRH) agonist in premenopausal women. Otherwise, ovarian cysts are likely to form following treatment with aromatase inhibitors.

Examples of aromatase inhibitors used to treat endometriosis

Aromatase inhibitors used to treat endometriosis include Femara (letrozole) and Arimidex (anastrozole).

Other information

The side effects of aromatase inhibitors are usually hot flashes and a reduced libido.

Women taking aromatase inhibitors should also be taking a calcium supplement, vitamin D, and a bisphosphonate to reduce bone loss (osteoporosis).

***

Endometriosis News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Emily holds a Ph.D. in Biochemistry from the University of Iowa and is currently a postdoctoral scholar at the University of Wisconsin-Madison. She graduated with a Masters in Chemistry from the Georgia Institute of Technology and holds a Bachelors in Biology and Chemistry from the University of Central Arkansas. Emily is passionate about science communication, and, in her free time, writes and illustrates children’s stories.
×
Emily holds a Ph.D. in Biochemistry from the University of Iowa and is currently a postdoctoral scholar at the University of Wisconsin-Madison. She graduated with a Masters in Chemistry from the Georgia Institute of Technology and holds a Bachelors in Biology and Chemistry from the University of Central Arkansas. Emily is passionate about science communication, and, in her free time, writes and illustrates children’s stories.
Latest Posts
    The User does not have any posts